Skip to content
Subscriber Only

POM Wonderful Loses Bid to Block FTC Deceptive-Ad Claims

Updated on

POM Wonderful LLC’s claims that its pomegranate products combat heart disease, prostate cancer and erectile dysfunction aren’t adequately backed by research, a federal appeals panel ruled, upholding a Federal Trade Commission ban on deceptive advertising by the company.

“We see no basis for setting aside the commission’s conclusion that many of POM’s ads made misleading or false claims,” U.S. Circuit Judge Sri Srinivasan wrote for a three-judge panel in Washington. “The FTC proscribes -- and the First Amendment does not protect -- deceptive and misleading advertisements.”